New developments in the pathogenesis of obesity-induced hypertension

Journal of Hypertension

Volumn 33, Issue 8, 2015, Pages 1499-1508

  Kotsis, Vasilios ^a   Nilsson, Peter ^b   Grassi, Guido ^c,d   Mancia, Giuseppe ^e   Redon, Josep ^f   Luft, Frank ^g   Schmieder, Roland ^h   Engeli, Stefan ⁱ   Stabouli, Stella ^a   Antza, Christina ^a   Pall, Denes ^j   Schlaich, Markus ^k   Jordan, Jens ^j  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^f UNIVERSITY OF VALENCIA   (Spain)

^g MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j UNIVERSITY OF DEBRECEN   (Hungary)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

a MSH; gut microbiota; hypertension; leptin; obesity; potassium; salt; sun light; sympathetic nervous system

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; GAMMA LIPOTROPIN; LEPTIN; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; POTASSIUM INTAKE; SODIUM INTAKE;

ADRENERGIC SYSTEM; APPETITE; ARTICLE; BLOOD PRESSURE MONITORING; CACHEXIA; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; EPIGENETICS; ETHNIC DIFFERENCE; EXERCISE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERITABILITY; HUMAN; HYPERTENSION; INTESTINE FLORA; NONHUMAN; NUTRITION; OBESITY; PATHOGENESIS; POTASSIUM INTAKE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR GENE; REGULATORY MECHANISM; SALT INTAKE; SLEEP DISORDERED BREATHING; SUN EXPOSURE; SUNLIGHT; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; ANIMAL; CARDIOVASCULAR DISEASE; COMPLICATION; GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTECTION; SODIUM INTAKE;

ANIMALS; APPETITE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; GENE-ENVIRONMENT INTERACTION; HUMANS; HYPERTENSION; LEPTIN; OBESITY; POTASSIUM, DIETARY; PROTECTIVE FACTORS; RECEPTOR, MELANOCORTIN, TYPE 4; SODIUM, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84941209260     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000645     Document Type: Article

References (114)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
2. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. National Institutes of Health. Obes Res 1998; 6 (Suppl 2): 51S-209S
3. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res 2010; 33: 386-393
4. Kramer H. Obesity and chronic kidney disease. Contrib Nephrol 2006; 151: 1-18
5. Frohlich ED. Clinical management of the obese hypertensive patient. Cardiol Rev 2002; 10: 127-138
6. Molenaar EA, Hwang SJ, Vasan RS, Grobbee DE, Meigs JB, D'Agostino RB Sr, et al. Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: The Framingham Heart Study. Diabetes Care 2008; 31: 1367-1372
7. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357
8. Lo JC, Chandra M, Sinaiko A, Daniels SR, Prineas RJ, Maring B, et al. Severe obesity in children: prevalence, persistence and relation to hypertension. Int J Pediatr Endocrinol 2014; 2014: 3
9. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-h ambulatory blood pressure and hypertension. Hypertension 2005; 45: 602-607
10. Stabouli S, Kotsis V, Papamichael C, Constantopoulos A, Zakopoulos N. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intima medial thickness. J Pediatr 2005; 147: 651-656
11. Kang IS, Pyun WB, Shin J, Kim JH, Kim SG, Shin GJ. Association between central obesity and circadian parameters of blood pressure from the Korean Ambulatory Blood Pressure Monitoring Registry: Kor-ABP Registry. J Korean Med Sci 2013; 28: 1461-1467
12. Bray GA, York DA. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 1979; 59: 719-809
13. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549
14. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14: 141-148
15. Friedman JM. Leptin, leptin receptors, and the control of body weight. Eur J Med Res 1997; 2: 7-13
16. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546
17. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432
18. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009; 462: 307-314
19. Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171-1174
20. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-414
21. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999; 17: 1949-1953
22. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8: 1298-1308
23. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-114
24. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-112
25. Hinney A, Schmidt A, Nottebom K, Heibült O, Becker I, Ziegler A, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 1483-1486
26. Mergen M, Mergen H, Ozata M, Oner R, Oner C. A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 2001; 86: 3448
27. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 2003; 27: 385-388
28. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34
29. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-279
30. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 34: 1085-1095
31. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52
32. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000; 97: 12339-12344
33. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000; 141: 3072-3079
34. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 2005; 46: 326-332
35. Albarado DC, McClaine J, Stephens JM, Mynatt RL, Ye J, Bannon AW, et al. Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology 2004; 145: 243-252
36. Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, Babin MJ, et al. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 2006; 147: 2183-2196
37. Böhm M, Wolff I, Scholzen TE, Robinson SJ, Healy E, Luger TA, et al. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005; 280: 5795-5802
38. Hedley SJ, Gawkrodger DJ, Weetman AP, Macneil S. alpha-MSH and melanogenesis in normal human adult melanocytes. Pigment Cell Res 1998; 1: 45-56
39. Song X, Mosby N, Yang J, Xu A, Abdel-Malek Z, Kadekaro AL. alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res 2009; 22: 809-818
40. Bray GA. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr 1991; 121: 1146-1162
41. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986; 61: 1081-1090
42. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633
43. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423-3429
44. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. Sympathetic nervous system activity is associated with obesityinduced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358
45. Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E, et al. Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007; 50: 862-868
46. Alvarez GE, Ballard TP, Beske SD, Davy KP. Subcutaneous obesity is not associated with sympathetic neural activation. Am J Physiol Heart Circ Physiol 2004; 287: H414-418
47. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endo Metab 1992; 262: E763-778
48. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S, Shionoiri H, Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol 1991; 261: R690-696
49. Miyajima E, Shigemasa T, Yamada Y, Tochikubo O, Ishii M. Angiotensin II blunts, while angiotensin converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Clin Exper Pharmacol Physiol 1999; 26: 797-802
50. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277
51. Grassi G, Seravalle G, Dell'Oro R, Trevano FQ, Bombelli M, Scopelliti F, et al. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens 2003; 21: 1761-1769
52. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533-2536
53. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36: 538-542
54. Bjorntorp P, Holm G, Rosmond R, Folkow B. Hypertension and the metabolic syndrome: closely related central origin?. Blood Press 2000; 9: 71-82
55. Dodt C, Wallin G, Fehm HL, Elam M. The stress hormone adrenocorticotropin enhances sympathetic outflow to the muscle vascular bed in humans. J Hypertens 1998; 16: 195-201
56. Grassi G, Seravalle G, Dell'Oro R, Turri C, Pasqualinotto L, Colombo M, Mancia G. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001; 38: 1316-1320
57. Narkiewicz K, van De Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772-776
58. Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F, et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 2005; 46: 321-325
59. Muxfeldt ES, Margallo V, Costa LM, Guimarães G, Cavalcante AH, Azevedo JC, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 2015; 65: 736-742
60. Fatouleh RH, Hammam E, Lundblad LC, Macey PM, McKenzie DK, Henderson LA, Macefield VG. Functional and structural changes in the brain associated with the increase in muscle sympathetic nerve activity in obstructive sleep apnoea. Neuroimage Clin 2014; 6: 275-283
61. Seravalle G, Colombo M, Perego P, Giardini V, Volpe M, Dell'Oro R, Mancia G, et al. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension 2014; 64: 431-437
62. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-897
63. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al., for the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
64. Kotsis V, Stabouli S. Renal denervation for resistant hypertension. N Engl J Med 2014; 371: 183
65. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894
66. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775
67. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, et al. Genomewide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24
68. Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet 2009; 5: e1000508
69. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948
70. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010; 42: 949-960
71. Wen W, Cho YS, Zheng W, Dorajoo R, Kato N, Qi L, et al. Metaanalysis identifies common variants associated with body mass index in East Asians. Nat Genet 2012; 44: 307-311
72. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gómez-Marín C, et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014; 507: 371-375
73. He D, Fu M, Miao S, Hotta K, Chandak GR, Xi B. FTO gene variant and risk of hypertension: a meta-analysis of 57 464 hypertensive cases and 41 256 controls. Metabolism 2014; 63: 633-639
74. Dankel SN, Fadnes DJ, Stavrum AK, Stansberg C, Holdhus R, Hoang T, et al. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One 2010; 5: e11033
75. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity: a potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735
76. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of noninsulin-dependent diabetes. Circulation 1990; 81: 987-995
77. Calhoun DA, Oparil S. Racial differences in the pathogenesis of hypertension. Am J Med Sci 1995; 310 (suppl 1): S86-S90
78. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990; 39: 1430-1435
79. Lillioja S, Nyomba BL, Saad MF, Ferraro R, Castillo C, Bennett PH, Bogardus C. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab 1991; 73: 866-876
80. Weyer C, Hanson R, Bogardus C, Pratley RE. A high fasting insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000; 49: 2094-2101
81. Tataranni PA, Cizza G, Snitker S, Gucciardo F, Lotsikas A, Chrousos GP, Ravussin E. Hypothalamic-pituitary-adrenal axis and sympathetic nervous system activities in Pima Indians and Caucasians. Metabolism 1999; 48: 395-399
82. Christin L, O'Connell M, Bogardus C, Danforth E Jr, Ravussin E. Norepinephrine turn-over and energy expenditure in Pima Indian and white men. Metabolism 1993; 42: 723-729
83. Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 2000; 36: 531-537
84. Begay RC, Chaudhari LS, Esparza-Romero J, Romero RU, Schulz LO. An exploration of gardens in Maycoba, Mexico: Change in the environment of a population genetically prone to diabetes. Int J Health Wellness Soc 2011; 1: 89-102
85. Lahmann PH, Lissner L, Gullberg B, Berglund G. Differences in body fat and central adiposity between Swedes and European immigrants: the Malmö Diet and Cancer Study. Obes Res 2000; 8: 620-631
86. Raza Q, Doak CM, Khan A, Nicolaou M, Seidell JC. Obesity and cardiovascular disease risk factors among the indigenous and immigrant Pakistani population: a systematic review. Obes Facts 2013; 6: 523-535
87. Bennet L, Nilsson P. Country of birth modifies the associations of body mass and hemoglobin A1c with office blood pressure in Middle Eastern immigrants and native Swedes. J Hypertens 2014; 32: 2362-2370
88. Tu W, Eckert GJ, Hannon TS, Liu H, Pratt LM, Wagner MA, et al. Racial differences in sensitivity of blood pressure to aldosterone. Hypertension 2014; 63: 1212-1218
89. Moleres A, Campión J, Milagro FI, Marcos A, Campoy C, Garagorri JM, et al. EVASYON Study Group. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J 2013; 27: 2504-2512
90. Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 2012; 15: 405-411
91. Rönn T, Volkov P, Davegårdh C, Dayeh T, Hall E, Olsson AH, et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet 2013; 9: e1003572
92. Graudal N, Jürgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low-and excessive-sodium diets are associated with increased mortality: a meta-analysis. Am J Hypertens 2014; 27: 1129-1137
93. Pavan L, Casiglia E, Braga LM, Winnicki M, Puato M, Pauletto P, Pessina AC. Effects of a traditional lifestyle on the cardiovascular risk profile: the Amondava population of the Brazilian Amazon. Comparison with matched African, Italian and Polish populations. J Hypertens 1999; 17: 749-756
94. Poulter NR, Khaw KT, Hopwood BE, Mugambi M, Peart WS, Rose G, Sever PS. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ 1990; 300: 967-972
95. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10
96. Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, et al. The influence of high versus low sodium intake on blood pressure and haemodynamics in patients with morbid obesity. J Hypertens 2013; 31: 2220-2229
97. Hall J. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-394
98. Titze J, Dahlmann A, Lerchl K, Kopp C, Rakova N, Schröder A, Luft FC. Spooky sodium balance. Kidney Int 2014; 85: 759-767
99. Terker AS, Zhang C, McCormick JA, Lazelle RA, Zhang C, Meermeier NP, et al. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab 2015; 21: 39-50
100. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, et al. A Proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler. Thromb Vasc Biol 2006; 26: 2541-2546
101. Sorof JM, Alexandrov A, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111: 61-66
102. Stabouli S, Kotsis V, Karagianni C, Zakopoulos N, Konstantopoulos A. Blood pressure and carotid artery intima-media thickness in children and adolescents: the role of obesity. Hellenic J Cardiol 2012; 53: 41-47
103. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358: 1400-1404
104. Stabouli S, Papakatsika S, Kotsis V. The role of obesity, salt and exercise on blood pressure in children and adolescents. Expert Rev Cardiovasc Ther 2011; 9: 753-761
105. Liu KH, Chan YL, Chan JC, Chan WB. Association of carotid intimamedia thickness with mesenteric, preperitoneal and subcutaneous fat thickness. Atherosclerosis 2005; 179: 299-304
106. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity (Silver Spring) 2006; 14: 1708-1715
107. Jordan J, Nilsson PM, Kotsis V, Olsen MH, Grassi G, Yumuk V, et al. Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and early vascular ageing. J Hypertens 2015; 33: 425-434
108. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001; 321: 225-236
109. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313
110. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995; 76: 1194-1197
111. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, Dávila-Román VG. Alterations in left ventricular structure and function in young healthy obese women. J Am Coll Cardiol 2004; 43: 1399-1404
112. Kotsis V, Stabouli S, Toumanidis S, Tsivgoulis G, Rizos Z, Trakateli C, et al. Obesity and daytime pulse pressure are predictors of left ventricular hypertrophy in true normotensive individuals. J Hypertens 2010; 28: 1065-1073
113. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 2014; 5: 190
114. Vandewalle G, Middleton B, Rajaratnam S, Stone B, Thorleifsdottir B, Arendt J, Dijk D. Robust circadian rhythm in heart rate and its variability influence of exogenous melatonin and photoperiod. J Sleep Res 2007; 16: 148-155